{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:52:40Z","timestamp":1762505560038},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jbspin.2009.04.009","type":"journal-article","created":{"date-parts":[[2010,1,9]],"date-time":"2010-01-09T09:35:35Z","timestamp":1263029735000},"page":"53-57","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis"],"prefix":"10.1016","volume":"77","author":[{"given":"Patrice","family":"Fardellone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Bresse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9gol\u00e8ne","family":"Bisot-Locard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Vigneron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Beresniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.04.009_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1503\/cmaj.070234","article-title":"Low bone mineral density and fracture burden in postmenopausal women","volume":"177","author":"Cranney","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jbspin.2009.04.009_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Adherence, patient preference and dosing frequency: Understanding the relationship","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2009.04.009_bib3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00198-005-0066-x","article-title":"The direct and indirect costs of the chronic management of osteoporosis: A prospective follow-up of 3440 active subjects","volume":"17","author":"Rabenda","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","article-title":"Requirements for DXA for the management of osteoporosis in Europe","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/jbmr.5650110719","article-title":"The prevalence of vertebral deformity in European men and women: The European vertebral osteoporosis study","volume":"11","author":"O\u2019Neill","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2009.04.009_bib6","unstructured":"DGS G. Ost\u00e9oporose. 2003; Mise \u00e0 jour."},{"key":"10.1016\/j.jbspin.2009.04.009_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00198-005-2031-0","article-title":"Incidence and cost of osteoporotic fracture in France during 2001. A methodological approach by the National Hospital Database","volume":"16","author":"Maravic","year":"2005","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00198-007-0410-4","article-title":"Adherence to treatment of osteoporosis: A need for study","volume":"18","author":"Lekkerkerker","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jbspin.2007.07.011","article-title":"Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis. A randomised crossover study (BALTO II)","volume":"75","author":"Hadji","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.04.009_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/BOR.0b013e328172dc1a","article-title":"New and emerging treatments for osteoporosis","volume":"19","author":"Maricic","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2009.04.009_bib11","first-page":"S171","article-title":"Economic impact of the previous year's adherence with bisphosphonates","volume":"21","author":"Briesacher","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2009.04.009_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s001980170036","article-title":"Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions","volume":"12","author":"Tosteson","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00019053-200725110-00003","article-title":"The cost-effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: A structured review of the literature","volume":"25","author":"Fleurence","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jbspin.2009.04.009_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.04.009_bib16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2009.04.009_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip intervention program study group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.04.009_bib19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2009.04.009_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s001980200125","article-title":"Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the more study. Multiple outcomes of raloxifene evaluation","volume":"13","author":"Siris","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.04.009_bib22","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of peripheral osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2009.04.009_bib23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.04.009_bib24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bone.2005.10.022","article-title":"Assessment of compliance with osteoporosis treatment and its consequences in a managed care population","volume":"38","author":"Huybrechts","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2009.04.009_bib25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2007.07.009","article-title":"Consequences of poor compliance with bisphosphonates","volume":"41","author":"Briesacher","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2009.04.009_bib26","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: The fracture intervention trial long-term extension (flex): A randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2009.04.009_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Watts nb, fracture risk remains reduced one year after discontinuation of risedronate","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib28","first-page":"14","article-title":"The hospital cost of vertebral fractures in the EU: Estimates using the national datasets","author":"Finnern","year":"2003","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00296-006-0180-x","article-title":"Estimation of direct unit costs associated with non vertebral osteoporotic fractures in five European countries","volume":"26","author":"Bouee","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2009.04.009_bib31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.clinthera.2006.10.013","article-title":"The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: A comparison of studies in the United States, the United Kingdom, and France","volume":"28","author":"Cramer","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2009.04.009_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jbspin.2006.02.006","article-title":"Adherence, persistence, concordance: Do we provide optimal management to our patients with osteoporosis?","volume":"73","author":"Cortet","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.04.009_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","article-title":"Compliance with drug therapy for postmenopausal osteoporosis","volume":"17","author":"Weycker","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2009.04.009_bib34","article-title":"A model of the public health impact of improved treatment persistence in postmenopausal osteoporosis in France","author":"Cott\u00e9","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.04.009_bib35","first-page":"2193","article-title":"Advantages and limitations of utility assessment methods in rheumatoid arthritis","volume":"34","author":"Beresniak","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2009.04.009_bib36","first-page":"353","article-title":"Guidelines and recommendations for French pharmacoeconomic studies","volume":"16","author":"Levy","year":"1998","journal-title":"J Econ Med"},{"key":"10.1016\/j.jbspin.2009.04.009_bib37","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.04.009_bib38","first-page":"i34","article-title":"Compliance and effect of bone protective treatment in elderly females: 5-year follow-up study","volume":"44","author":"Doherty","year":"2005","journal-title":"Rheumatology"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T03:50:14Z","timestamp":1544759414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1297319X09002012"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.04.009","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}